Trial · NCT05507476
Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy
NCT05507476, Not applicable, Completed, Zagazig University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy. Trials, record NCT05507476. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05507476
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy
- NCT number
- NCT05507476
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 52 participants, actual
- Lead sponsor
- Zagazig University
- Conditions
- Anesthesia
- Interventions
- Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray, Epinephrine topical 1:100,000 Nasal Packs
- First posted
- 2022-08-19
- Last updated
- 2024-10-01
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intraoperative blood loss | Measurement will be done at the 30th minutes of the start of surgery. | Estimation of intraoperative blood loss will be done at 30th minutes of surgery. by calculating the loss of blood and irrigation saline in 50 mL-graded suction canisters. |
| Primary | Intraoperative blood loss | Measurement will be done at 60th minutes of the start of surgery. | Estimation of intraoperative blood loss will be done at 60th minutes of surgery. by calculating the loss of blood and irrigation saline in 50 mL-graded suction canisters. |
| Secondary | The Surgical field clarity | at the end of surgery | The quality of surgical field based on BOEZAART grading system(0 no bleeding; 1 slight bleeding: no suctioning is needed; 2 slight bleeding: occasional suctioning needed;, 3 sight bleeding: frequent suctioning required, bleeding threatens surgical field a few seconds after suction is removed; 4 moderate bleeding: frequent suctioning required and bleeding threatens surgical field directly after suction is removed; 5 severe bleeding: constant suctioning required) |
| Secondary | Change in heart rate (HR) in beat per minute | will be recorded at 2 minutes, 5 minutes, 10 minutes, 30 minutes and 60 minutes after topical epinephrine packs insertion. | Change in heart rate (HR) from baseline. |
| Secondary | Change mean arterial blood pressure (MAP) in mmHg | will be recorded at 2 minutes, 5 minutes, 10 minutes, 30 minutes and 60 minutes after topical epinephrine packs insertion. | Change mean arterial blood pressure (MAP) from baseline. |
| Secondary | Change oxygen saturation (SPO2) | will be recorded at 2 minutes, 5 minutes, 10 minutes, 30 minutes and 60 minutes after topical epinephrine packs insertion. | Change oxygen saturation (SPO2) from baseline. |
| Secondary | Change in serum sodium level | preoperative and after 12 hours postoperative | Serum sodium level will be measured pre \& postoperative to detect and manage any sodium disturbances. |
| Secondary | The surgeon's satisfaction | At the end of surgery | The surgeon was asked to rate satisfaction at the end of surgery (4 =excellent, 3 = good, 2 = fair, 1 = poor, 0 = extremely poor). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers6
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05507476
GET https://conductscience.org/api/trials/v1/NCT05507476/registered